We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGAU
3101
Centerra Gold
CGAU
$4.15B
$712 ﹤0.01%
106
– –
AMPX icon
3102
Amprius Technologies
AMPX
$1.75B
$564 ﹤0.01%
444
– –
STI icon
3103
Solidion Technology
STI
$65.4M
$477 ﹤0.01%
+17
New +$1.73K
QVCGB
3104
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$465 ﹤0.01%
2
– –
TAK icon
3105
Takeda Pharmaceutical
TAK
$55.5B
$194 ﹤0.01%
15
– –
TLRY icon
3106
Tilray
TLRY
$637M
$138 ﹤0.01%
8
– –
UBX
3107
DELISTED
Unity Biotechnology
UBX
$135 ﹤0.01%
100
– –
DNMR
3108
DELISTED
Danimer Scientific, Inc.
DNMR
$112 ﹤0.01%
5
-175
-97% -$5.44K
DM
3109
DELISTED
Desktop Metal, Inc.
DM
$87 ﹤0.01%
21
-2,767
-99% -$18.9K
UMC icon
3110
United Microelectronic
UMC
$48.8B
$18 ﹤0.01%
2
– –
VIP
3111
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$33.9M
$13 ﹤0.01%
5
– –
NKLA
3112
DELISTED
Nikola Corporation Common Stock
NKLA
$7 ﹤0.01%
1
-1,966
-100% -$35.1K
ACET icon
3113
Adicet Bio
ACET
$77.3M
– –
-134
Closed -$5.04K
ACRS icon
3114
Aclaris Therapeutics
ACRS
$866M
– –
-6,900
Closed -$8.56K
ALLK
3115
DELISTED
Allakos
ALLK
– –
-5,490
Closed -$6.92K
AMLX icon
3116
Amylyx Pharmaceuticals
AMLX
$2.52B
– –
-5,046
Closed -$14.3K
AMWL icon
3117
American Well
AMWL
$220M
– –
-1,218
Closed -$19.8K
APG icon
3118
APi Group
APG
$18.8B
– –
-31,784
Closed -$832K
ARTNA icon
3119
Artesian Resources
ARTNA
$369M
– –
-917
Closed -$34K
ASRT
3120
DELISTED
Assertio
ASRT
– –
-544
Closed -$7.83K
ATI icon
3121
ATI
ATI
$31B
– –
-13,035
Closed -$667K
ATOM icon
3122
Atomera
ATOM
$215M
– –
-1,466
Closed -$9.03K
ATRA icon
3123
Atara Biotherapeutics
ATRA
$77.8M
– –
-271
Closed -$4.71K
BCAB icon
3124
BioAtla
BCAB
$5.64M
– –
-73
Closed -$12.6K
BFLY icon
3125
Butterfly Network
BFLY
$2.42B
– –
-13,763
Closed -$14.9K
123 124
125
126 127

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.